Transitioning Patients From IVIg to SCIg in CIDP

City of Selkirk Proclamation - GBS and CIDP Awareness Month

WHEREAS:          the Month of May, has been internationally designated as “GBS and CIDP Awareness Month” to educate the public and to focus attention on Guillain-Barré Syndrome (GBS) and Chronic Inflammatory… The post City of Selkirk Proclamation – GBS and CIDP Awareness Month appeared first on City of Selkirk.

Transitioning Patients From IVIg to SCIg in CIDP

Panelists discuss how transitioning stable patients with chronic inflammatory demyelinating polyneuropathy (CIDP) from intravenous immunoglobulin (IVIg) to subcutaneous immunoglobulin (SCIg) can offer greater convenience and independence, with careful consideration of dosing, patient education, and ongoing monitoring to ensure successful treatment outcomes.